These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20816123)

  • 1. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events.
    Chrysant SG; Chrysant GS
    Am J Cardiol; 2010 Sep; 106(6):825-9. PubMed ID: 20816123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
    Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?
    Messerli FH; Panjrath GS
    J Am Coll Cardiol; 2009 Nov; 54(20):1827-34. PubMed ID: 19892233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Target values in hypertension treatment. Will they apply in older patients with hypertension, diabetics and in patients with IHD?].
    Widimský J
    Vnitr Lek; 2009 Sep; 55(9):833-40. PubMed ID: 19785385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a lower target blood pressure for people with heart disease.
    Rosendorff C; Black HR
    Curr Opin Cardiol; 2009 Jul; 24(4):318-24. PubMed ID: 19395951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of aggressive blood glucose and blood pressure control in diabetic hypertensive subjects.
    Chrysant SG; Chrysant GS
    Am J Cardiol; 2011 Jun; 107(12):1856-61. PubMed ID: 21481823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension treatment guidelines: practical implications.
    Choi KL; Bakris GL
    Semin Nephrol; 2005 Jul; 25(4):198-209. PubMed ID: 16202692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension, coronary heart disease and stroke: should the blood pressure J-curve be a concern?].
    Nogueira JB
    Rev Port Cardiol; 2013 Feb; 32(2):139-44. PubMed ID: 23351918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure lowering and stroke.
    Saini M; Shuaib A
    Expert Rev Neurother; 2010 Feb; 10(2):225-41. PubMed ID: 20136379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradigm has shifted to systolic blood pressure.
    Black HR
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S3-7. PubMed ID: 15592571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining blood pressure targets in high-risk patients?: lessons from coronary endpoints in recent randomized clinical trials.
    Volpe M; Tocci G
    Am J Hypertens; 2011 Oct; 24(10):1060-8. PubMed ID: 21677698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the implications for the community of the discrepancy between the theory and practice of BP control?
    Jackson R
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S25-8. PubMed ID: 7562894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.